Oxcarbazepine
Product Images NDC 63629-2075

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 63629-2075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636292075)

Label for Oxcarbazepine Tablets USP 300 mg by Bryant Ranch Prepack. The label shows the product name, strength (300 mg), prescription only status, and quantity of 500 tablets. Manufactured by LGM Pharma Solutions, LLC, Irvine, CA and relabeled by Bryant Ranch Prepack, Inc., Burbank, CA. Storage and safety instructions are also included.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

Chemical structure of oxcarbazepine, showing its bicyclic structure with a ketone group and an amide substituent attached to the nitrogen atom in the central ring.*

FDA Label Image

Figure 1 (Oxcarbazepine 02)

A line graph showing exit rates over time from day 2 to day 11 at 8 am for two treatment groups: Oxcarbazepine (solid line) and Placebo (dotted line). The vertical axis represents the exit rate from 0.0 to 1.0, and the horizontal axis shows days on trial. The chart includes a log-rank test p-value of 0.0001.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

A Kaplan-Meier curve chart showing seizure rate over time in days from first dose to first seizure. Two treatment groups are compared: Oxcarbazepine (solid line) and Placebo (dotted line). The chart includes a p-value of 0.046 from a log-rank test assessing the difference between groups.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

A survival curve chart showing exit rate over time (days) for two treatment groups labeled as HIGH and LOW. The x-axis represents time to exit in days, ranging from 0 to 130, and the y-axis represents exit rate from 0.0 to 1.0. The chart includes a log-rank test p-value of 0.0001, indicating a statistical comparison between the two curves, with the LOW group exhibiting a faster exit rate than the HIGH group.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

A Kaplan-Meier survival curve illustrating the exit rate over time in days for two treatment groups, labeled HIGH and LOW. The x-axis represents time to exit in days, and the y-axis represents the exit rate. The LOW group shows a faster and higher exit rate compared to the HIGH group, with a log-rank test p-value of 0.0001 indicated on the graph.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.